Verax Biomedical Nets $2.8M
August 17, 2012- Share:
Verax Biomedical, developer of rapid tests for the detection of bacterial contaminants, has raised $2.8 million of a planned $5 million in bridge financing from SightLine Partners, CNF Investments, BioVentures Investors and KB Partners.
- Share:
-
-
-
-